Research Site — Nanjing

Public research footprint of Research Site, compiled from the ClinicalTrials.gov public registry.

514

Registered studies

286

Active

139

Recruiting now

199

Completed

Stopped or withdrawn

Most-studied conditions

Type 2 Diabetes Mellitus · Non-small Cell Lung Cancer · HR Low-Positive/HER2-Negative Breast Neoplasms · Moderate to Severe Crohn's Disease

Recently updated registry entries

NCT04613596 — Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase… (Recruiting)
NCT06935357 — A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin… (Recruiting)
NCT02519348 — A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.